These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase. Wu J; Pistolozzi M; Liu S; Tan W Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity. Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707 [TBL] [Abstract][Full Text] [Related]
10. Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors. Krátký M; Štěpánková Š; Brablíková M; Svrčková K; Švarcová M; Vinšová J Curr Top Med Chem; 2020; 20(23):2106-2117. PubMed ID: 32814531 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors. Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949 [TBL] [Abstract][Full Text] [Related]
13. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors. Cavallaro V; Moglie YF; Murray AP; Radivoy GE Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857 [TBL] [Abstract][Full Text] [Related]
14. N-[3,5-Bis(trifluoromethyl)phenyl]-5-bromo-2-hydroxybenzamide Analogues: Novel Acetyl- and Butyrylcholinesterase Inhibitors. Krátký M; Jaklová K; Štěpánková Š; Svrčková K; Pflégr V; Vinšová J Curr Top Med Chem; 2020; 20(23):2094-2105. PubMed ID: 32814530 [TBL] [Abstract][Full Text] [Related]
15. Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesterase. Wiemann J; Loesche A; Csuk R Bioorg Chem; 2017 Oct; 74():145-157. PubMed ID: 28797788 [TBL] [Abstract][Full Text] [Related]
16. Efficient synthesis of novel dialkyl-3-cyanopropylphosphate derivatives and evaluation of their anticholinesterase activity. Aouani I; Sellami B; Lahbib K; Cavalier JF; Touil S Bioorg Chem; 2017 Jun; 72():301-307. PubMed ID: 28500956 [TBL] [Abstract][Full Text] [Related]
17. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase. Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors. Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors. Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]